S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The A.I. story nobody is telling you (Read ASAP) (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Biden replacement revealed? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
He Is Giving Away Bitcoin (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The A.I. story nobody is telling you (Read ASAP) (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Biden replacement revealed? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
He Is Giving Away Bitcoin (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The A.I. story nobody is telling you (Read ASAP) (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Biden replacement revealed? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
He Is Giving Away Bitcoin (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The A.I. story nobody is telling you (Read ASAP) (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Biden replacement revealed? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
He Is Giving Away Bitcoin (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial

Compare Stocks

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Compare

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
C$0.11
C$0.11
C$0.02
▼
C$0.16
C$952KN/A3.16 million shs1.31 million shs
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
C$0.36
+2.9%		C$0.38
C$0.23
▼
C$0.47
C$48.48M0.2872,244 shs5,500 shs
AdvisorShares Q Portfolio Blended Allocation ETF stock logo
QPT
AdvisorShares Q Portfolio Blended Allocation ETF
$19.10
+0.1%		$19.10
$18.63
▼
$27.54
$1.91MN/A1,912 shs19,400 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
0.00%0.00%0.00%0.00%0.00%
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
0.00%-2.78%-6.67%-15.66%-11.39%
AdvisorShares Q Portfolio Blended Allocation ETF stock logo
QPT
AdvisorShares Q Portfolio Blended Allocation ETF
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
N/AN/AN/AN/AN/AN/AN/AN/A
AdvisorShares Q Portfolio Blended Allocation ETF stock logo
QPT
AdvisorShares Q Portfolio Blended Allocation ETF
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/AN/AN/AN/A
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
3.00
BuyN/AN/A
AdvisorShares Q Portfolio Blended Allocation ETF stock logo
QPT
AdvisorShares Q Portfolio Blended Allocation ETF
0.00
N/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/AN/AC$0.01 per share8.75C$0.00 per shareN/A
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
C$22.42M2.16C$0.09 per share4.13C$0.20 per share1.78
AdvisorShares Q Portfolio Blended Allocation ETF stock logo
QPT
AdvisorShares Q Portfolio Blended Allocation ETF
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/A-C$0.01N/A∞N/AN/AN/AN/AN/A
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
C$3.72MC$0.0311.83∞N/A16.57%14.66%1.87%5/9/2024 (Estimated)
AdvisorShares Q Portfolio Blended Allocation ETF stock logo
QPT
AdvisorShares Q Portfolio Blended Allocation ETF
N/AN/A0.00∞N/AN/AN/AN/AN/A

Latest ICO, QPT, MBX, and CDY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/14/2024Q1 2024
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
N/AC$0.02+C$0.02C$0.02C$8.10 millionC$8.41 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/AN/AN/AN/AN/A
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
N/AN/AN/AN/AN/A
AdvisorShares Q Portfolio Blended Allocation ETF stock logo
QPT
AdvisorShares Q Portfolio Blended Allocation ETF
$0.080.42%N/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/A
1.14
1.12
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
24.53
8.53
5.57
AdvisorShares Q Portfolio Blended Allocation ETF stock logo
QPT
AdvisorShares Q Portfolio Blended Allocation ETF
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/A
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
0.42%
AdvisorShares Q Portfolio Blended Allocation ETF stock logo
QPT
AdvisorShares Q Portfolio Blended Allocation ETF
N/A

Insider Ownership

CompanyInsider Ownership
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/A
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
14.07%
AdvisorShares Q Portfolio Blended Allocation ETF stock logo
QPT
AdvisorShares Q Portfolio Blended Allocation ETF
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/A9.07 millionN/ANot Optionable
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
N/A136.55 millionN/ANot Optionable
AdvisorShares Q Portfolio Blended Allocation ETF stock logo
QPT
AdvisorShares Q Portfolio Blended Allocation ETF
N/A100,000N/ANot Optionable

ICO, QPT, MBX, and CDY Headlines

No headlines for this company have been tracked by MarketBeat.com

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

iCo Therapeutics logo

iCo Therapeutics

CVE:ICO
iCo Therapeutics Inc., a biotechnology company, focuses on the identification, development, and commercialization of drug candidates to treat ocular and infectious diseases. Its in-licensed drug candidates include iCo-008, a human monoclonal antibody, which is in Phase II clinical trial to treat ulcerative colitis and bullous pemphigoid; and Oral AmpB Delivery System, an oral formulation of Amphotericin B that is in Phase 1b clinical trial for the treatment of systemic fungal and parasitic infections. The company was incorporated in 2005 and is headquartered in Vancouver, Canada.
Microbix Biosystems logo

Microbix Biosystems

TSE:MBX
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
AdvisorShares Q Portfolio Blended Allocation ETF logo

AdvisorShares Q Portfolio Blended Allocation ETF

NYSEARCA:QPT